(HP) Helmerich Payne - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4234521015
Stock: Land Rigs, Offshore Rigs, Drilling Tech, Real Estate
Total Rating 52
Risk 78
Buy Signal 0.62
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.67% |
| Yield on Cost 5y | 5.69% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 89.9% |
| Payout Ratio | 4.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 41.9% |
| Relative Tail Risk | -4.69% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.77 |
| Alpha | -8.51 |
| Character TTM | |
|---|---|
| Beta | 1.544 |
| Beta Downside | 2.336 |
| Drawdowns 3y | |
|---|---|
| Max DD | 64.42% |
| CAGR/Max DD | -0.05 |
Description: HP Helmerich Payne January 15, 2026
Helmerich & Payne Inc. (NYSE: HP) supplies drilling solutions and technologies to oil-and-gas producers, operating through three geographic segments: North America Solutions (centered in Texas), Offshore Solutions (U.S. Gulf, North Sea, Norwegian Sea, Caspian Sea, etc.), and International Solutions (Saudi Arabia, Argentina, Bahrain, Oman, Germany, Kuwait). The firm also holds commercial real-estate assets, including a shopping center, and traces its roots back to 1920 in Tulsa, Oklahoma.
Key operating metrics from the most recent fiscal year show roughly $1.5 billion in revenue, a rig fleet of 16 units with an average day-rate near $150 k, and a backlog of about $300 million, indicating strong utilization (≈ 90 %).
Sector-wide, HP’s outlook is tied to oil-price trends, U.S. shale capital spending, and offshore drilling demand, which are currently influenced by OPEC+ production decisions and the ongoing transition toward higher-mix natural-gas projects.
For a deeper, data-driven view of HP’s valuation dynamics, you may find the analytics on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: -163.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -1.54 > 1.0 |
| NWC/Revenue: 17.37% < 20% (prev 27.03%; Δ -9.66% < -1%) |
| CFO/TA 0.08 > 3% & CFO 543.0m > Net Income -163.7m |
| Net Debt (1.84b) to EBITDA (658.8m): 2.79 < 3 |
| Current Ratio: 1.80 > 1.5 & < 3 |
| Outstanding Shares: last quarter (99.4m) vs 12m ago 0.45% < -2% |
| Gross Margin: 15.70% > 18% (prev 0.26%; Δ 1544 % > 0.5%) |
| Asset Turnover: 60.00% > 50% (prev 47.68%; Δ 12.32% > 0%) |
| Interest Coverage Ratio: 0.31 > 6 (EBITDA TTM 658.8m / Interest Expense TTM 107.8m) |
Altman Z'' 2.67
| A: 0.10 (Total Current Assets 1.47b - Total Current Liabilities 814.8m) / Total Assets 6.71b |
| B: 0.39 (Retained Earnings 2.62b / Total Assets 6.71b) |
| C: 0.01 (EBIT TTM 33.7m / Avg Total Assets 6.24b) |
| D: 0.69 (Book Value of Equity 2.68b / Total Liabilities 3.88b) |
| Altman-Z'' Score: 2.67 = A |
Beneish M -2.30
| DSRI: 1.34 (Receivables 782.6m/429.9m, Revenue 3.75b/2.76b) |
| GMI: 1.69 (GM 15.70% / 26.47%) |
| AQI: 0.46 (AQ_t 0.12 / AQ_t-1 0.26) |
| SGI: 1.36 (Revenue 3.75b / 2.76b) |
| TATA: -0.11 (NI -163.7m - CFO 543.0m) / TA 6.71b) |
| Beneish M-Score: -2.30 (Cap -4..+1) = BBB |
What is the price of HP shares?
As of February 07, 2026, the stock is trading at USD 35.97 with a total of 1,697,052 shares traded.
Over the past week, the price has changed by +6.17%, over one month by +15.81%, over three months by +37.70% and over the past year by +35.79%.
Over the past week, the price has changed by +6.17%, over one month by +15.81%, over three months by +37.70% and over the past year by +35.79%.
Is HP a buy, sell or hold?
Helmerich Payne has received a consensus analysts rating of 3.18.
Therefor, it is recommend to hold HP.
- StrongBuy: 2
- Buy: 2
- Hold: 11
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the HP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 31.7 | -11.8% |
| Analysts Target Price | 31.7 | -11.8% |
| ValueRay Target Price | 38.5 | 6.9% |
HP Fundamental Data Overview February 01, 2026
P/E Forward = 96.1538
P/S = 0.8994
P/B = 1.2574
P/EG = 5.7805
Revenue TTM = 3.75b USD
EBIT TTM = 33.7m USD
EBITDA TTM = 658.8m USD
Long Term Debt = 2.06b USD (from longTermDebt, last quarter)
Short Term Debt = 6.86m USD (from shortTermDebt, last quarter)
Debt = 2.06b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.84b USD (from netDebt column, last quarter)
Enterprise Value = 5.24b USD (3.37b + Debt 2.06b - CCE 196.8m)
Interest Coverage Ratio = 0.31 (Ebit TTM 33.7m / Interest Expense TTM 107.8m)
EV/FCF = 44.92x (Enterprise Value 5.24b / FCF TTM 116.6m)
FCF Yield = 2.23% (FCF TTM 116.6m / Enterprise Value 5.24b)
FCF Margin = 3.11% (FCF TTM 116.6m / Revenue TTM 3.75b)
Net Margin = -4.37% (Net Income TTM -163.7m / Revenue TTM 3.75b)
Gross Margin = 15.70% ((Revenue TTM 3.75b - Cost of Revenue TTM 3.16b) / Revenue TTM)
Gross Margin QoQ = 10.67% (prev 15.10%)
Tobins Q-Ratio = 0.78 (Enterprise Value 5.24b / Total Assets 6.71b)
Interest Expense / Debt = 1.36% (Interest Expense 28.0m / Debt 2.06b)
Taxrate = 21.0% (US default 21%)
NOPAT = 26.6m (EBIT 33.7m * (1 - 21.00%))
Current Ratio = 1.80 (Total Current Assets 1.47b / Total Current Liabilities 814.8m)
Debt / Equity = 0.76 (Debt 2.06b / totalStockholderEquity, last quarter 2.72b)
Debt / EBITDA = 2.79 (Net Debt 1.84b / EBITDA 658.8m)
Debt / FCF = 15.78 (Net Debt 1.84b / FCF TTM 116.6m)
Total Stockholder Equity = 2.87b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.62% (Net Income -163.7m / Total Assets 6.71b)
RoE = -5.70% (Net Income TTM -163.7m / Total Stockholder Equity 2.87b)
RoCE = 0.68% (EBIT 33.7m / Capital Employed (Equity 2.87b + L.T.Debt 2.06b))
RoIC = 0.54% (NOPAT 26.6m / Invested Capital 4.91b)
WACC = 7.60% (E(3.37b)/V(5.43b) * Re(11.60%) + D(2.06b)/V(5.43b) * Rd(1.36%) * (1-Tc(0.21)))
Discount Rate = 11.60% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.09%
[DCF Debug] Terminal Value 72.09% ; FCFF base≈145.8m ; Y1≈95.7m ; Y5≈43.7m
Fair Price DCF = N/A (negative equity: EV 919.4m - Net Debt 1.84b = -920.3m; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -26.82 | EPS CAGR: 38.90% | SUE: -0.38 | # QB: 0
Revenue Correlation: 83.98 | Revenue CAGR: 27.25% | SUE: 0.76 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.07 | Chg30d=+0.005 | Revisions Net=+3 | Analysts=6
EPS current Year (2026-09-30): EPS=0.46 | Chg30d=+0.017 | Revisions Net=+3 | Growth EPS=-50.6% | Growth Revenue=+5.5%
EPS next Year (2027-09-30): EPS=0.87 | Chg30d=+0.060 | Revisions Net=-1 | Growth EPS=+87.1% | Growth Revenue=+3.2%
P/S = 0.8994
P/B = 1.2574
P/EG = 5.7805
Revenue TTM = 3.75b USD
EBIT TTM = 33.7m USD
EBITDA TTM = 658.8m USD
Long Term Debt = 2.06b USD (from longTermDebt, last quarter)
Short Term Debt = 6.86m USD (from shortTermDebt, last quarter)
Debt = 2.06b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.84b USD (from netDebt column, last quarter)
Enterprise Value = 5.24b USD (3.37b + Debt 2.06b - CCE 196.8m)
Interest Coverage Ratio = 0.31 (Ebit TTM 33.7m / Interest Expense TTM 107.8m)
EV/FCF = 44.92x (Enterprise Value 5.24b / FCF TTM 116.6m)
FCF Yield = 2.23% (FCF TTM 116.6m / Enterprise Value 5.24b)
FCF Margin = 3.11% (FCF TTM 116.6m / Revenue TTM 3.75b)
Net Margin = -4.37% (Net Income TTM -163.7m / Revenue TTM 3.75b)
Gross Margin = 15.70% ((Revenue TTM 3.75b - Cost of Revenue TTM 3.16b) / Revenue TTM)
Gross Margin QoQ = 10.67% (prev 15.10%)
Tobins Q-Ratio = 0.78 (Enterprise Value 5.24b / Total Assets 6.71b)
Interest Expense / Debt = 1.36% (Interest Expense 28.0m / Debt 2.06b)
Taxrate = 21.0% (US default 21%)
NOPAT = 26.6m (EBIT 33.7m * (1 - 21.00%))
Current Ratio = 1.80 (Total Current Assets 1.47b / Total Current Liabilities 814.8m)
Debt / Equity = 0.76 (Debt 2.06b / totalStockholderEquity, last quarter 2.72b)
Debt / EBITDA = 2.79 (Net Debt 1.84b / EBITDA 658.8m)
Debt / FCF = 15.78 (Net Debt 1.84b / FCF TTM 116.6m)
Total Stockholder Equity = 2.87b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.62% (Net Income -163.7m / Total Assets 6.71b)
RoE = -5.70% (Net Income TTM -163.7m / Total Stockholder Equity 2.87b)
RoCE = 0.68% (EBIT 33.7m / Capital Employed (Equity 2.87b + L.T.Debt 2.06b))
RoIC = 0.54% (NOPAT 26.6m / Invested Capital 4.91b)
WACC = 7.60% (E(3.37b)/V(5.43b) * Re(11.60%) + D(2.06b)/V(5.43b) * Rd(1.36%) * (1-Tc(0.21)))
Discount Rate = 11.60% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.09%
[DCF Debug] Terminal Value 72.09% ; FCFF base≈145.8m ; Y1≈95.7m ; Y5≈43.7m
Fair Price DCF = N/A (negative equity: EV 919.4m - Net Debt 1.84b = -920.3m; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -26.82 | EPS CAGR: 38.90% | SUE: -0.38 | # QB: 0
Revenue Correlation: 83.98 | Revenue CAGR: 27.25% | SUE: 0.76 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.07 | Chg30d=+0.005 | Revisions Net=+3 | Analysts=6
EPS current Year (2026-09-30): EPS=0.46 | Chg30d=+0.017 | Revisions Net=+3 | Growth EPS=-50.6% | Growth Revenue=+5.5%
EPS next Year (2027-09-30): EPS=0.87 | Chg30d=+0.060 | Revisions Net=-1 | Growth EPS=+87.1% | Growth Revenue=+3.2%